Rchr
J-GLOBAL ID:201201080717915760   Update date: Oct. 31, 2024

Ito Shin

イトウ シン | Ito Shin
Affiliation and department:
Job title: Researcher
Research field  (1): Tumor biology
Research keywords  (2): リキッドバイオプシー ,  ゲノム解析
Research theme for competitive and other funds  (1):
  • 2021 - 2024 Pilot study for identification of familial lung cancer susceptible genes
Papers (18):
  • Shin Ito, Mika Ando, Shuichi Aoki, Satoshi Soma, Jie Zhang, Naohiro Hirano, Ryosuke Kashiwagi, Keigo Murakami, Shingo Yoshimachi, Hideaki Sato, et al. Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers. Cancer science. 2024
  • Shin Ito, Kyoji Tsurumi, Norihisa Shindo, Satoshi Soma, Kazunori Yamaguchi, Keiichi Tamai, Mai Mochizuki, Haruna Fujimori, Mami Morita, Kana Watanabe, et al. Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With EGFR-mutated Lung Adenocarcinoma. Anticancer research. 2023. 43. 11. 5031-5040
  • Shingo Miyabe, Shin Ito, Ikuro Sato, Jiro Abe, Keiichi Tamai, Mai Mochizuki, Haruna Fujimori, Kazunori Yamaguchi, Norihisa Shindo, Hiroshi Shima, et al. Clinical and genomic features of non-small cell lung cancer occurring in families. Thoracic Cancer. 2023
  • Shin Ito, Aya Hashimoto, Kazunori Yamaguchi, Sadafumi Kawamura, Shingo Myoen, Maki Ogawa, Ikuro Sato, Takamichi Minato, Shingo Miyabe, Akira Nakazato, et al. A novel 8.57-kb deletion of the upstream region of PRKAR1A in a family with Carney complex. Molecular Genetics & Genomic Medicine. 2022. 10. 3. e1884
  • Takamichi Minato, Shin Ito, Bin Li, Haruna Fujimori, Mai Mochizuki, Kazunori Yamaguchi, Keiichi Tamai, Muneaki Shimada, Hideki Tokunaga, Shogo Shigeta, et al. Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125. Gynecologic Oncology Reports. 2021. 38. 100847-100847
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page